{
    "2019-09-30": [
        [
            {
                "time": "",
                "original_text": "国家组织药品集中采购和使用试点将在全国推开，这些医药股已站在风口",
                "features": {
                    "keywords": [
                        "药品集中采购",
                        "使用试点",
                        "医药股",
                        "全国推开"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "业绩向好+比较优势，医药有望再度成为“抱团焦点”||医药行业2019年10月份投资月报【兴证医药】",
                "features": {
                    "keywords": [
                        "业绩向好",
                        "比较优势",
                        "医药",
                        "抱团焦点",
                        "投资月报"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业增速平稳，集采扩面落地，持续推荐高性价比标的",
                "features": {
                    "keywords": [
                        "医药行业",
                        "增速平稳",
                        "集采扩面",
                        "高性价比标的"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "2019年医药三季报业绩前瞻||三季报预期向好，关注“变化”、稳守“核心资产”【兴证医药】",
                "features": {
                    "keywords": [
                        "医药三季报",
                        "业绩前瞻",
                        "三季报预期向好",
                        "核心资产"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报: 带量采购扩面落地, 转型创新不二选择",
                "features": {
                    "keywords": [
                        "医药行业",
                        "带量采购",
                        "扩面落地",
                        "转型创新"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}